4.8 Article

Bladder Cancer in 2010 How Far Have We Come?

期刊

CA-A CANCER JOURNAL FOR CLINICIANS
卷 60, 期 4, 页码 244-272

出版社

WILEY
DOI: 10.3322/caac.20077

关键词

-

类别

资金

  1. Pfizer

向作者/读者索取更多资源

Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high-risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010;60:244-272. (C) 2010 American Cancer Society, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据